Abstract
Background: Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these 3 disorders. Content: Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest, and a myriad of host metabolic pathways. Conclusion: Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes. Copyright © 2013 American Association for Clinical Chemistry.
Cite
CITATION STYLE
Devaraj, S., Hemarajata, P., & Versalovic, J. (2013, April). The human gut microbiome and body metabolism: Implications for obesity and diabetes. Clinical Chemistry. https://doi.org/10.1373/clinchem.2012.187617
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.